To suspend temporarily the duty on Hexadecyl.
Legislative Progress
Introduced
April 27, 2012
Latest Action
May 2, 2012
Primary Sponsor
Rodney P. FrelinghuysenRepublican(NJ)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
29pct
5d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2012 · fourth_quarter · Trade (domestic/foreign)
Issues related to Miscellaneous Tariff legislation, including bills H.R. 5065, H.R. 5267, H.R. 5268, H.R. 5269, H.R. 5270, H.R. 5271, S. 2898, S. 2899, S. 2900, S. 2901, S. 2902
Client expense: Not reported · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE
2012 · third_quarter · Trade (domestic/foreign)
Issues related to Miscellaneous Tariff legislation, including bills H.R. 5065, H.R. 5267, H.R. 5268, H.R. 5269, H.R. 5270, H.R. 5271, S. 2898, S. 2899, S. 2900, S. 2901, S. 2902
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE
2012 · second_quarter · Trade (domestic/foreign)
Issues related to Miscellaneous Tariff legislation, including bills H.R. 5065, H.R. 5267, H.R. 5268, H.R. 5269, H.R. 5270, H.R. 5271, S. 2898, S. 2899, S. 2900, S. 2901, S. 2902
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Tariff (miscellaneous tariff bills)
The temporary suspension of duty on the specified chemical products for the following chemicals: Oryzalin (H.R. 5061); Lambda-cyhalothrin (H.R. 5062); Acephate (H.R. 5063); Ziram 76DF (H.R. 5064); Cypermethrin (H.R. 5065); Thiophanate Methyl with Application Adjuvants (H.R. 5066); Thiophanate-Methyl Technical (H.R. 5067); and Asulox (H.R. 5068).
Client expense: Not reported · Firm income: Not reported